199 related articles for article (PubMed ID: 27824082)
21. LncRNA Meg3 protects endothelial function by regulating the DNA damage response.
Shihabudeen Haider Ali MS; Cheng X; Moran M; Haemmig S; Naldrett MJ; Alvarez S; Feinberg MW; Sun X
Nucleic Acids Res; 2019 Feb; 47(3):1505-1522. PubMed ID: 30476192
[TBL] [Abstract][Full Text] [Related]
22. Involvement of endoplasmic reticulum stress and p53 in lncRNA MEG3-induced human hepatoma HepG2 cell apoptosis.
Chen RP; Huang ZL; Liu LX; Xiang MQ; Li GP; Feng JL; Liu B; Wu LF
Oncol Rep; 2016 Sep; 36(3):1649-57. PubMed ID: 27432655
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of long noncoding RNA MEG3 impairs VEGF-stimulated endothelial sprouting angiogenesis via modulating VEGFR2 expression in human umbilical vein endothelial cells.
Ruan W; Zhao F; Zhao S; Zhang L; Shi L; Pang T
Gene; 2018 Apr; 649():32-39. PubMed ID: 29391273
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA MEG3 knockdown attenuates endoplasmic reticulum stress-mediated apoptosis by targeting p53 following myocardial infarction.
Li X; Zhao J; Geng J; Chen F; Wei Z; Liu C; Zhang X; Li Q; Zhang J; Gao L; Xie J; Xu B
J Cell Mol Med; 2019 Dec; 23(12):8369-8380. PubMed ID: 31631486
[TBL] [Abstract][Full Text] [Related]
25. LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway.
Sun KX; Wu DD; Chen S; Zhao Y; Zong ZH
Apoptosis; 2017 Dec; 22(12):1543-1552. PubMed ID: 29094270
[TBL] [Abstract][Full Text] [Related]
26. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells.
Feng SQ; Zhang XY; Fan HT; Sun QJ; Zhang M
Neoplasma; 2018 Nov; 65(6):925-932. PubMed ID: 29940769
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MT1JP functions as a tumor suppressor by interacting with TIAR to modulate the p53 pathway.
Liu L; Yue H; Liu Q; Yuan J; Li J; Wei G; Chen X; Lu Y; Guo M; Luo J; Chen R
Oncotarget; 2016 Mar; 7(13):15787-800. PubMed ID: 26909858
[TBL] [Abstract][Full Text] [Related]
29. Silencing of the long non-coding RNA MEG3 suppresses the apoptosis of aortic endothelial cells in mice with chronic intermittent hypoxia via downregulation of HIF-1α by competitively binding to microRNA-135a.
Ding H; Huang J; Wu D; Zhao J; Huang J; Lin Q
J Thorac Dis; 2020 May; 12(5):1903-1916. PubMed ID: 32642094
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.
Zhou C; Ye L; Jiang C; Bai J; Chi Y; Zhang H
Tumour Biol; 2015 Dec; 36(12):9179-88. PubMed ID: 26088446
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of LncRNA GHET1 suppresses prostate cancer cell proliferation by inhibiting HIF-1α/Notch-1 signaling pathway via KLF2.
Zhu Y; Tong Y; Wu J; Liu Y; Zhao M
Biofactors; 2019 May; 45(3):364-373. PubMed ID: 30609158
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNAs in osteosarcoma via various signaling pathways.
Han J; Shen X
J Clin Lab Anal; 2020 Jun; 34(6):e23317. PubMed ID: 32249459
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA HOTTIP promotes hypoxia-induced epithelial-mesenchymal transition of malignant glioma by regulating the miR-101/ZEB1 axis.
Zhang S; Wang W; Liu G; Xie S; Li Q; Li Y; Lin Z
Biomed Pharmacother; 2017 Nov; 95():711-720. PubMed ID: 28886531
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.
Yin DD; Liu ZJ; Zhang E; Kong R; Zhang ZH; Guo RH
Tumour Biol; 2015 Jun; 36(6):4851-9. PubMed ID: 25636452
[TBL] [Abstract][Full Text] [Related]
35. The Shc protein RAI promotes an adaptive cell survival program in hypoxic neuroblastoma cells.
Criscuoli M; Filippi I; Osti D; Aldinucci C; Guerrini G; Pelicci G; Carraro F; Naldini A
J Cell Physiol; 2018 May; 233(5):4282-4293. PubMed ID: 29057481
[TBL] [Abstract][Full Text] [Related]
36. Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway.
Uroda T; Anastasakou E; Rossi A; Teulon JM; Pellequer JL; Annibale P; Pessey O; Inga A; Chillón I; Marcia M
Mol Cell; 2019 Sep; 75(5):982-995.e9. PubMed ID: 31444106
[TBL] [Abstract][Full Text] [Related]
37. [Overexpression of lncRNA MEG3 inhibits proliferation and invasion of glioblastoma U251 cells
Luo Q; Zhang F; Li W; Wang F; Wu L; Huang B
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):141-145. PubMed ID: 33509767
[TBL] [Abstract][Full Text] [Related]
38. The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer.
Chen X; Liu M; Meng F; Sun B; Jin X; Jia C
J Cell Biochem; 2019 Jan; 120(1):243-252. PubMed ID: 30216500
[TBL] [Abstract][Full Text] [Related]
39. Calreticulin Regulates VEGF-A in Neuroblastoma Cells.
Weng WC; Lin KH; Wu PY; Lu YC; Weng YC; Wang BJ; Liao YF; Hsu WM; Lee WT; Lee H
Mol Neurobiol; 2015 Aug; 52(1):758-70. PubMed ID: 25288151
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
Xia Y; He Z; Liu B; Wang P; Chen Y
Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
